Found: 18
Select item for more details and to access through your institution.
Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.
- Published in:
- Diabetologia, 2016, v. 59, n. 9, p. 2018, doi. 10.1007/s00125-016-4000-x
- By:
- Publication type:
- Article
Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 166, doi. 10.1111/dom.14212
- By:
- Publication type:
- Article
Evaluation of the innate immunostimulatory potential of originator and non-originator copies of insulin glargine in an in vitro human immune model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0197478
- By:
- Publication type:
- Article
Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 541, p. 1, doi. 10.1126/scitranslmed.aav8824
- By:
- Publication type:
- Article
Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor.
- Published in:
- Diabetes, 2013, v. 62, n. 10, p. 3553, doi. 10.2337/db13-0249
- By:
- Publication type:
- Article
Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites, IGF-I, and Human Insulin on Insulin and IGF-I Receptor Signaling.
- Published in:
- Diabetes, 2013, v. 62, n. 7, p. 2539, doi. 10.2337/db12-1773
- By:
- Publication type:
- Article
Chitinase-3-like protein 1 protects skeletal muscle from TNFa-induced inflammation and insulin resistance.
- Published in:
- Biochemical Journal, 2014, v. 459, n. 3, p. 479, doi. 10.1042/BJ20131151
- By:
- Publication type:
- Article
The signalling conformation of the insulin receptor ectodomain.
- Published in:
- Nature Communications, 2018, v. 9, p. 1, doi. 10.1038/s41467-018-06826-6
- By:
- Publication type:
- Article
Progress towards the replacement of the rabbit blood sugar bioidentity assay by an in vitro test for batch release of insulins in quality control.
- Published in:
- Altex, 2017, v. 34, n. 4, p. 565, doi. 10.14573/altex.1708091
- By:
- Publication type:
- Article
Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041992
- By:
- Publication type:
- Article
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009540
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 5, p. i, doi. 10.1002/bmc.4846
- By:
- Publication type:
- Article
High‐throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 5, p. 1, doi. 10.1002/bmc.4790
- By:
- Publication type:
- Article
Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.591293
- By:
- Publication type:
- Article
Molecular basis for inhibiting human glucose transporters by exofacial inhibitors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30326-3
- By:
- Publication type:
- Article
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0410-9
- By:
- Publication type:
- Article
Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.00598
- By:
- Publication type:
- Article